ABSTRACT DEADLINE EXTENDED: 10TH EDCTP Forum - 'EQUITY IN RESEARCH FOR HEALTH', 17-21 October 2021, Maputo, Mozambique
EDCTP invites submission of abstracts highlighting original contributions on strategic EDCTP research topics and on research capacity strengthening, linked to the Forum theme. Investigators involved in EDCTP-funded projects are encouraged to use this opportunity to share new developments and results from their projects. The deadline for abstracts is 28 June 2021.
Format and eligibility:
Abstracts must be submitted in English and should not exceed 300 words
Abstracts should follow the format: Background; Methods; Results; Conclusions
Abstracts must not have been published or submitted for presentation to any other national or international meeting.Submission: Abstracts must be submitted via the online system by 28 June 2021. Only abstracts submitted online by the deadline will be considered. Detailed instructions are available in the online submission system - https://edctpforum.eventsair.com/edctp-forum-2021/abstract-submission. For questions regarding abstracts, please contact the EDCTP Forum Team (forum@edctp.org).
Evaluation procedure:
All submitted abstracts will be reviewed by the Forum scientific programme committee and external experts, in collaboration with EDCTP secretariat members. Selection of abstracts will be based on the following criteria: Abstract quality; Relevance to the Forum theme and to EDCTP; Significance of the reported results
Applicants will be notified of the outcome of the review by 14 July 2021.
Please note that the final decision on whether the abstract is accepted and, if so, whether it will be for a poster or oral presentation will be made by EDCTP and the Forum Programme Committee.
Presenting authors whose abstracts have been accepted will receive further instructions for presenting their abstract. All presenters will be required to pre-record their presentations.
Articles
Virtual Workshop: Recognition And Control Of Mtb Infected Cells: From Basics To The Clinic | 13 – 14June 2023
The Stop
TB Partnership Working Group on New TB Vaccines (WGNV) and the National
Institute for Allergy and Infectious Diseases (NIAID)are
co-hosting a workshop on the topic of Recognition and Control of Mtb
Infected Cells: From Basics to the Clinic. This workshop is intended to address
the need for correlates and to identify platforms that measure recognition or
control of the infected cell - especially in humans - as identified in the EDCTP/AIGHD Global Roadmap for
Research and Development of New TB Vaccines and the Strategic Framework for
New TB Vaccines in the Stop TB Partnership Global Plan to End TB 2023 - 2030.
The overall goals of this workshop
are to:
- elucidate the mechanisms by
which the immune system recognizes the Mtb-infected cell
- explore the degree to which
such recognition can lead to control of the intracellular microbe, and
- discuss the translational
implications of these observations
The workshop format will be largely
discussion-based. Each session will have three short presentations that will
provide a high-level overview of key topics within the session theme, followed
by a discussion between the session chairs, speakers, and participants.
Click here
to view the programme and
speakers.
This workshop is free of charge and
open to any participants interested in this topic.
Ssi/Isid Infectious Diseases Research Fellowships | Deadline For Applications: 16 June 2023
The International Society for Infectious Diseases (ISID) and the Swiss
Society for Infectious Diseases (SSI) are inviting applications for their joint
Infectious Diseases Research Fellowship Program. The purpose of this programme
is to support infectious disease physicians and scientists from under-resourced
countries through multidisciplinary clinical and laboratory training at a
select biomedical institution in Zurich, Switzerland. The one-year SSI/ISID
Fellowship programme is open to applicants who are 40 years or younger,
citizens and permanent residents of under-resourced countries or Eastern
Europe. The deadline for applications is 16 June 2023.
More information: https://na.eventscloud.com/eSites/748378/Homepage
Ethical Review Of Decentralized Clinical Trials (Dcts): Tools, Resources & Best Practices.
The MRCT Center and Medable convened a multi-stakeholder task force to address ethical and regulatory opportunities and challenges related to Decentralized Clinical Trials (DCTs). Join them on June 20, from 10 - 11 AM ET, for a joint webinar entitled, "Ethical Review of Decentralized Clinical Trials (DCTs): Tools, Resources & Best Practices."
During the webinar, Barbara Bierer (MRCT Center), Pam Tenaerts
(Medable) and Leanne Madre (Medable) will present a framework, recommendations,
and tools organized around 3 DCT domains: People, Remote Data Collection, and
Data Oversight. Best practices for the ethical review, approval, and conduct of
DCTs will be provided.
Clinical trial stakeholders (IRB/ECs,
HRPP, sites, sponsors, investigators, and others) to register for the webinar here